Premium
Identification of a secretory protein c19orf10 activated in hepatocellular carcinoma
Author(s) -
Sunagozaka Hajime,
Honda Masao,
Yamashita Taro,
Nishino Ryuhei,
Takatori Hajime,
Arai Kuniaki,
Yamashita Tatsuya,
Sakai Yoshio,
Kaneko Shuichi
Publication year - 2011
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.25830
Subject(s) - cell growth , gene knockdown , biology , hepatocellular carcinoma , cancer research , protein kinase a , microbiology and biotechnology , protein kinase b , gene , cell cycle , cell culture , alpha fetoprotein , recombinant dna , kinase , signal transduction , biochemistry , genetics
The identification of genes involved in tumor growth is crucial for the development of inventive anticancer treatments. Here, we have cloned a 17‐kDa secretory protein encoded by c19orf10 from hepatocellular carcinoma (HCC) serial analysis of gene expression libraries. Gene expression analysis indicated that c19orf10 was overexpressed in approximately two‐thirds of HCC tissues compared to the adjacent noncancerous liver tissues, and its expression was significantly positively correlated with that of alpha‐fetoprotein (AFP). Overexpression of c19orf10 enhanced cell proliferation of AFP‐negative HLE cells, whereas knockdown of c19orf10 inhibited cell proliferation of AFP‐positive Hep3B and HuH7 cells along with G1 cell cycle arrest. Supplementation of recombinant c19orf10 protein in culture media enhanced cell proliferation in HLE cells, and this effect was abolished by the addition of antibodies developed against c19orf10. Intriguingly, c19orf10 could regulate cell proliferation through the activation of Akt/mitogen‐activated protein kinase pathways. Taken together, these data suggest that c19orf10 might be one of the growth factors and potential molecular targets activated in HCC.